Form 4: BioCardia CEO Peter Altman Acquires Additional Shares
SEC Form 4 Filing
BioCardia's CEO, Peter Altman, recently purchased 800 shares of the company's common stock at an average price of $2.04 per share.
Summary
- On April 4, 2025, Peter Altman, the President and CEO of BioCardia, Inc., acquired 800 shares of common stock.
- The purchase was made at a weighted average price of $2.04 per share, with individual trades ranging from $2.01 to $2.09.
- Following this transaction, Altman directly owns 111,520 shares of BioCardia's common stock.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. The CEO's purchase indicates confidence, but the amount is relatively small.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often viewed positively by investors, as it suggests that a company's leadership believes the stock is undervalued. However, it's important to consider the size of the purchase relative to the executive's overall holdings and the company's market capitalization.
Stakeholder Impact
- The stock purchase could have a slightly positive impact on shareholder sentiment.
Key Dates
| Date | Description |
|---|---|
| 04/04/2025 | Date of the stock purchase transaction. |
| 04/07/2025 | Date of signature on the Form 4 filing. |
Keywords
BioCardia, BCDA, Peter Altman, Stock Purchase, CEO, Insider Trading, Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.